(MENAFN) Green Cross Corp., a South Korean pharmaceutical company, said its 2014 exports to top USD200 million, becoming the first South Korean drugmaker to reach the mark, Yonhap News reported.
The pharmaceutical firm said its outbound shipments were led by a surge in demand for vaccine products, which totaled USD60 million last year, up 60 percent from a year earlier.
In 2010, the drug firm started delivering a seasonal flu vaccine to the Pan American Health Organization (PAHO) in the wake of an influenza outbreak, and its exports amounted to USD38 million.
"This year, we will see a continued rise in exports and seek to tap deeper into the South American region and the Middle East area as well," an official at the firm said.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.